EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Effect of Dopaminergic Therapies in Parkinson’s Disease on Non-Motor Symptoms

Monika Jampolska iD, Katarzyna Kaczyńska iD

International Journal of Molecular Sciences · 12.12.2025 · 26 (24) · 11996

DOI: 10.3390/ijms262411996 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.12.2025. Verfasst von Monika Jampolska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Poland. Hauptthemen laut MEDLINE: Parkinson Disease, Dopamine Agents, Dopamine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a neurodegenerative disorder due to damage of the nigrostriatal pathway and consequent dopamine (DA) deficiency. The main classic symptoms are those related to motor disturbances, such as postural instability, resting tremor, bradykinesia, and muscle rigidity. Other symptoms, such as non-motor symptoms, do not attract the attention of clinicians and are often overlooked, remaining undiagnosed and untreated, even though they can significantly impair quality of life of PD patients. Dopaminergic therapy is primarily aimed at treating motor symptoms, although it can bring measurable benefits for various non-motor problems. This narrative review analyzes the scientific literature and describes the most recent information on the impact of dopaminergic therapy on non-motor symptoms in PD; both its beneficial and undesirable effects. We discuss evidence that non-motor symptoms such as cardiovascular dysfunction, thermoregulatory issues, dysphagia and drooling, urinary symptoms, pain, neuropsychiatric symptoms, and sleep disorders, including obstructive sleep apnea, can be effectively treated with various dopaminergic strategies, while noting the contraindications and adverse effects of these therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDopamine AgentsDopamineHumansQuality of LifeSleep Wake Disorders

Stichwörter der Autor:innen

Parkinson’s diseaseautonomic dysfunctioncognitive impairmentdopaminergic therapyneuropsychiatric disordersnon-motor symptomspainsleep-related disorders

Substanzen

Dopamine AgentsDopamine

Autor:innen und Institutionen

  • Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Poland.

ORCID-Profile: Monika Jampolska, Katarzyna Kaczyńska

Zitieren

APA

Jampolska, M., & Kaczyńska, K. (2025). The Effect of Dopaminergic Therapies in Parkinson’s Disease on Non-Motor Symptoms. International Journal of Molecular Sciences, 26(24), 11996. https://doi.org/10.3390/ijms262411996

Vancouver

Jampolska M, Kaczyńska K. The Effect of Dopaminergic Therapies in Parkinson’s Disease on Non-Motor Symptoms. International Journal of Molecular Sciences. 2025;26(24):11996. doi:10.3390/ijms262411996

BibTeX
@article{Jampolska2025,
  author = {Jampolska, Monika and Kaczyńska, Katarzyna},
  title = {The Effect of Dopaminergic Therapies in Parkinson’s Disease on Non-Motor Symptoms},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {11996},
  doi = {10.3390/ijms262411996}
}
Kostenlos starten →